Common Contracts
5 similar Distribution Agreement contracts by Diana Shipping Inc., Evofem Biosciences, Inc., Heart Test Laboratories, Inc., others
HEART TEST LABORATORIES, INC. Up to $3,250,000 of Common Stock EQUITY DISTRIBUTION AGREEMENTDistribution Agreement • September 18th, 2023 • Heart Test Laboratories, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York
Heart Test Laboratories, Inc., a Texas corporation (the “Company”), proposes to issue and sell through Maxim Group LLC, as exclusive sales agent (the “Agent”), shares of common stock, par value $0.001 per share, of the Company (the “Common Stock”), having an aggregate offering price of up to US$3,250,000 (the Common Stock subject to this Equity Distribution Agreement (this “Agreement”) being referred to herein as the “Shares”) on terms set forth herein and subject to the limitations set forth in Section 2(a) hereof. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
NexGel, Inc. Up to $2,700,000 Shares of Common Stock Equity Distribution AgreementDistribution Agreement • April 13th, 2022 • Nexgel, Inc. • Surgical & medical instruments & apparatus • New York
NexGel, Inc., a Delaware corporation (the "Company"), proposes to issue and sell through Maxim Group LLC (the "Agent"), as exclusive sales agent, shares of common stock, par value $0.001 per share ("Common Stock"), of the Company (the "Shares") having an aggregate offering price of up to $2,700,000 on terms set forth herein. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
Diana Shipping Inc. Up to $200,000,000 Shares of Common Stock Equity Distribution AgreementDistribution Agreement • April 23rd, 2021 • Diana Shipping Inc. • Deep sea foreign transportation of freight • New York
Diana Shipping Inc., a company incorporated under the laws of the Marshall Islands (the "Company"), proposes to issue and sell through Maxim Group LLC (the "Agent"), as sales agent, shares of common stock, par value $0.01 per share ("Common Stock"), of the Company (the "Shares") having an aggregate offering price of up to $200,000,000 on terms set forth herein. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
SINTX Technologies, Inc. Up to $15,000,000 Shares of Common Stock Equity Distribution AgreementDistribution Agreement • February 26th, 2021 • Sintx Technologies, Inc. • Surgical & medical instruments & apparatus • New York
SINTX Technologies, Inc., a Delaware corporation (the “Company”), proposes to issue and sell through Maxim Group LLC (the “Agent”), as exclusive sales agent, shares of common stock, par value $0.01 per share (“Common Stock”), of the Company (the “Shares”) having an aggregate offering price of up to $15,000,000 on terms set forth herein. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
EVOFEM BIOSCIENCES, INC. EQUITY DISTRIBUTION AGREEMENTDistribution Agreement • November 18th, 2019 • Evofem Biosciences, Inc. • Pharmaceutical preparations • New York
As further set forth in this agreement (this “Agreement”), Evofem Biosciences, Inc., a company organized under the laws of the State of Delaware (the “Company”), proposes to issue and sell from time to time through Piper Jaffray & Co. (the “Agent”), as sales agent, the Company’s common stock, par value $0.0001 per share (the “Common Stock”) having an aggregate offering price of up to $50 million (such shares of Common Stock to be sold pursuant to this Agreement, the “Shares”) on terms set forth herein. Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitation set forth in Section 2 of this Agreement on the number of shares of Shares issued and sold under this Agreement shall be the sole responsibility of the Company, and the Agent shall have no obligation in connection with such compliance.
